EC Pulmonology and Respiratory Medicine

Asthma, a chronic inflammatory disease of the airways, affects millions globally. While traditionally managed with long-term medication, the concept of remission in asthma has garnered increasing attention. This article reviews the current understanding of asthma remission, including definitions, mechanisms, predictors, and the implications for clinical practice.

 Keywords: Asthma Remission; Predictors of Remission of Asthma

1. Global Initiative for Asthma (GINA). “Global Strategy for Asthma Management and Prevention” (2022).
2. Boulet LP., et al. "Asthma and exercise-induced bronchoconstriction”. Paediatric Respiratory Reviews (2018).
3. Reddel HK., et al. "Asthma control and exacerbations”. American Journal of Respiratory and Critical Care Medicine (2009).
4. Wenzel SE. "Asthma phenotypes: the evolution from clinical to molecular approaches”. Nature Medicine5 (2012): 716-725.
5. Bateman ED., et al. "Overall asthma control: the relationship between current control and future risk”. The Journal of Allergy and Clinical Immunology3 (2010): 600-608.
6. Ducharme FM., et al. "Long-acting beta2-agonists versus inhaled corticosteroids”. Cochrane Database of Systematic Reviews (2010).
7. Martinez FD. "Asthma endotypes: a new approach to classification”. Journal of Allergy and Clinical Immunology (2011).
8. O'Byrne PM., et al. "Risk of asthma exacerbations in patients taking ICS/LABA”. The Lancet (2020).
9. Bel EH. "Predicting exacerbations in asthma”. Current Opinion in Pulmonary Medicine1 (2013): 25-32.
10. Kuo CHS., et al. "T-helper cell type 2 (Th2) and Non-Th2 molecular phenotypes of asthma using sputum proteomic profiling and validation”. Journal of Allergy and Clinical Immunology6 (2015): 1534-1541.
11. Zetterquist W and Johannson SGO. "Biomarkers in asthma: An update”. Allergy, Asthma and Clinical Immunology 1 (2020): 1-10.
12. Fahy JV. "Type 2 Inflammation in asthma-Present in most, absent in many”. Nature Reviews Immunology1 (2015): 57-65.
13. Bigler J., et al. "A severe asthma disease signature from gene expression profiling of peripheral blood from U-BIOPRED cohorts”. European Respiratory Journal5 (2017): 1602295.
14. Comhair SAA., et al. "Metabolomic endotype of asthma”. American Journal of Respiratory and Critical Care Medicine8 (2015): 759-772.
15. Woodruff PG., et al. "T-helper type 2-driven inflammation defines major subphenotypes of asthma”. American Journal of Respiratory and Critical Care Medicine5 (2009): 388-395.
16. Aboagye E and Bhavnani SK. "Integrative multi-omics approach to identify biomarkers of asthma remission”. BMC Medical Genomics2 (2018): 1-12.
17. Sorkness CA., et al. "Long-term evaluation of anti-inflammatory treatment”. Chest (2007).
18. Busse WW., et al. "Mechanisms of asthma”. The New England Journal of Medicine (2015).
19. Fitzpatrick AM., et al. "Severe asthma in childhood: insights into treatment”. The Lancet (2016).
20. Holt PG., et al. "Role of immune factors in the pathogenesis of asthma”. Clinical and Experimental Allergy (2011).
21. Holgate ST., et al. "Inflammatory basis of asthma”. Annals of Internal Medicine (2007).
22. Jackson DJ., et al. "The role of viruses in asthma”. Clinical and Experimental Allergy (2012).
23. Papadopoulos NG., et al. "Impact of infection on asthma”. Journal of Allergy and Clinical Immunology (2012).
24. Schatz M., et al. "Asthma control test”. Journal of Allergy and Clinical Immunology (2006).
25. Barnes PJ., et al. "Pathophysiology of asthma”. Annual Review of Physiology (2016).
26. Bousquet J., et al. "Asthma research: current trends”. The Journal of Allergy and Clinical Immunology (2009).
27. Humbert M., et al. "The future of asthma therapy”. The European Respiratory Journal (2014).
28. Lemanske RF., et al. "Asthma prevention and treatment”. The Journal of Allergy and Clinical Immunology (2010).
29. Lötvall J and Akdis CA. "Precision medicine in asthma: Towards a new understanding of asthma remission”. The Lancet Respiratory Medicine2 (2023): 111-120.
30. Uhl R., et al. "Biologic therapies and asthma remission: Current evidence and future directions”. Journal of Allergy and Clinical Immunology: In Practice1 (2022): 53-62.
31. Auvreau GM., et al. "The role of eosinophils in asthma remission: current evidence and future directions”. Allergy, Asthma and Clinical Immunology1 (2021): 1-12.
32. Alagappan VKT., et al. "Understanding asthma remission: The role of regulatory T cells and immune modulation”. Allergy8 (2020): 1987-1999.
33. Hung KF and Wenzel SE. "Asthma phenotypes and endotypes: Moving toward precision medicine in asthma remission”. European Respiratory Journal4 (2022): 2101855.